Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of CancerGuoquan Wan, Luoting Yu, Tian-Wen Luo et al.|Journal of Medicinal Chemistry|2022Cited by 28
Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian CancerQiangsheng Zhang, Luoting Yu, Qiang Feng et al.|Journal of Medicinal Chemistry|2023Cited by 24